Molecular Targets in Malignant Pleural Mesothelioma Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|10|12|1235-1244

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.12, 2009-12, pp. : 1235-1244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current chemotherapeutic treatment of malignant pleural mesothelioma

By Nowak Anna K   Byrne Michael J   Millward Michael J   Alvarez John M   Robinson Bruce WS  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2441-2449

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 855-867

Bentham Science Publishers

Access to resources Recommend Favorite

Vinflunine shows promise in the treatment of patients with malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies

By  

Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. : 824-849

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed/cisplatin worth it in malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite